---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-23-000004"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:28:48.528484+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Dexcom reports Q4 2022 preliminary revenue at least $815M (+17% YoY); FY2023 guidance $3.35-3.49B

## Summary
- Q4 2022 preliminary revenue at least $815M, up 17% YoY; U.S. $606M, international $209M.
- FY2022 preliminary revenue ~$2.91B, up 19% YoY on a reported basis.
- FY2023 revenue guidance $3.35B-$3.49B, representing 15-20% growth over 2022.
- FY2023 non-GAAP gross profit margin expected 62-63%; non-GAAP operating margin ~16.5%.
- CEO cites strong customer growth and G7 CGM regulatory clearances as key drivers.

## SEC filing metadata
- accession: 0001093557-23-000004
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355723000004/0001093557-23-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355723000004/dxcm-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-23-000004
- JSON: https://secwatch.observer/filing/0001093557-23-000004.json
- Plain text: https://secwatch.observer/filing/0001093557-23-000004.txt

## Key facts
- Earnings Releases
  DEXCOM INC reported fiscal year 2022 results: revenue approximately $2.91 billion.
  - Period: fiscal year 2022
  - Revenue: approximately $2.91 billion
  - Result: preliminary results
  source text: total preliminary, unaudited revenue is expected to be approximately $2.91 billion
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355723000004/0001093557-23-000004-index.htm
- Earnings Releases
  DEXCOM INC reported fiscal year 2023 results: revenue approximately $3.35 billion to $3.49 billion. Guidance initiated.
  - Period: fiscal year 2023
  - Revenue: approximately $3.35 billion to $3.49 billion
  - Guidance: initiated
  - Result: guidance update
  source text: initial financial outlook for fiscal year 2023, including an anticipated range for total revenue of approximately $3.35 billion to $3.49 billion
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355723000004/0001093557-23-000004-index.htm
- Earnings Releases
  DEXCOM INC reported the fourth quarter ended December 31, 2022 results: revenue at least $815 million.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: at least $815 million
  - Result: preliminary results
  source text: preliminary, unaudited revenue for the fourth quarter ended December 31, 2022 is expected to be at least $815 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355723000004/0001093557-23-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.